logo
Spied: Mercedes Ditching Annoying Twin-Spoke Steering Wheel in New C-Class

Spied: Mercedes Ditching Annoying Twin-Spoke Steering Wheel in New C-Class

The Drive4 days ago
Stefan Baldauf / SB-Medien
The latest car news, reviews, and features.
It won't be long now before Mercedes-Benz unveils the updated 2026 C-Class, and our spies have now caught the long-roof version wearing only a token disguise both inside and out. Most of the same bits that were covered on the C-Class sedan spied earlier this month are similarly concealed on this prototype, but this is our first good look at the compact's new interior, and if you were put off by the spit-spoke design of the current compact's steering wheel, it appears you're in luck. The updated car appears to be equipped with a conventional three-spoke design.
But let's start outside. As befits a relatively small update, this prototype's exterior doesn't really look all that different. The nose appears more pinched on the new car, suggesting we may get a new grille design, and like the sedan, the new wagon gets lighted star elements its headlights. If the same will be mirrored in the rear on the wagon, the vinyl wrap is concealing the details.
The story's similar inside. Mercedes is sticking to a two-screen layout with separate infotainment and IP displays. The tablet-like floating design of the existing center screen carries over, though this prototype lacks the slotted-spoke steering wheel design offered in the current C-Class. If that's true for the entire range, we won't exactly be sad to see it go.
One other thing won't be changing: The C-Class Wagon isn't currently offered here, nor do we have any reason to suspect that will change with the refresh. You can browse the full gallery of pics below.
Got a tip? Send it our way at tips@thedrive.com.
.article-sidebar]:pt-0>
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

U.S. And EU Reach Trade Deal—Setting Tariffs at 15%
U.S. And EU Reach Trade Deal—Setting Tariffs at 15%

Forbes

time20 minutes ago

  • Forbes

U.S. And EU Reach Trade Deal—Setting Tariffs at 15%

The U.S. has agreed to a trade deal with the European Union, President Donald Trump announced Sunday afternoon, agreeing to a 15% tariff rate on most exports, including European cars, from EU countries—just days before the Aug. 1 deadline set for Trump's 'reciprocal' tariffs. US President Donald Trump meets with European Commission President Ursula von der Leyen in Scotland ... More on Sunday. AFP via Getty Images This is a breaking story and will be updated.

EU, US Reach Deal to Avoid Trump Tariff Hike Before Deadline
EU, US Reach Deal to Avoid Trump Tariff Hike Before Deadline

Bloomberg

time20 minutes ago

  • Bloomberg

EU, US Reach Deal to Avoid Trump Tariff Hike Before Deadline

By , Suzanne Lynch, Jorge Valero, and Hadriana Lowenkron Updated on Save The US and European Union agreed to a deal that will see the bloc face 15% tariffs on most of its exports, including automobiles, staving off a trade war that could have delivered a hammer blow to the global economy. The pact comes less than a week before a Friday deadline for President Donald Trump's higher tariffs to take effect. The president in May threatened to impose a 50% duty on nearly all EU goods, adding pressure that accelerated negotiations, before lowering that to 30%.

Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup
Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup

Yahoo

timean hour ago

  • Yahoo

Merck (MRK) as a Reliable Dividend Player in the Dogs of the Dow Lineup

Merck & Co., Inc. (NYSE:MRK) is included among the 11 Dogs of the Dow Dividend Stocks to Buy Now. A close-up of a person's hand holding a bottle of pharmaceuticals. Merck & Co., Inc. (NYSE:MRK) has faced stock pressure due to its reliance on Keytruda but is diversifying. On July 9, Merck announced it would acquire UK biotech Verona Pharma for $10 billion, adding Ohtuvayre, a promising COPD treatment approved last year, to its portfolio. Ohtuvayre has had a strong launch and is being studied for more uses. Some analysts predict its sales could reach $4 billion, potentially making it another blockbuster for Merck. In its first quarter earnings, Merck & Co., Inc. (NYSE:MRK) highlighted that it began the year with strong progress, driven by growing contributions from its recently commercialized medicines and vaccines, along with ongoing advancements in its pipeline. It is focused and determined to fully capitalize on near-term opportunities while swiftly advancing the next wave of innovations that will improve patient outcomes and create long-term value for all stakeholders. Merck & Co., Inc. (NYSE:MRK) is also popular because of its dividend growth history, which spans 16 consecutive years. Currently, the company offers a quarterly dividend of $0.81 per share and has a dividend yield of 3.82%, as of July 26. While we acknowledge the potential of MRK as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: and Disclosure: None. Fehler beim Abrufen der Daten Melden Sie sich an, um Ihr Portfolio aufzurufen. Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten Fehler beim Abrufen der Daten

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store